Literature DB >> 1748037

Effect of partial gastrectomy on serum anti-Helicobacter pylori immunoglobulins in peptic ulcer patients.

C B Lamers1, P N Rieu, R A Veenendaal, W van Duijn, G J Offerhaus, H J Joosten, A S Peña.   

Abstract

Since biliary enterogastric reflux is suggested to eradicate gastric infection with Helicobacter pylori (HP), we have investigated in a prospective randomized study the effect of partial gastrectomy with either Billroth II or Roux-en-Y anastomosis on infection with HP as assessed by the titers of IgG and IgA antibodies against HP in serum. These antibodies were measured by ELISA in serum of 22 patients before and at 10 days and 6, 15, and 24 months after either Billroth II (N = 11) or Roux-en-Y (N = 11) gastrectomy for peptic ulcer. All patients had HP demonstrated in their preoperative endoscopic gastric biopsies. The preoperative serum IgA antibodies against HP (anti-HP IgA) were increased in 20 of the 22 patients (range 0.21-1.69) while the IgG antibodies (anti-HP IgG) were increased in all 22 patients (range 0.38-1.31). Four of the Billroth II patients had clearance of HP from gastric biopsies accompanied by rapid and pronounced decrease of anti-HP IgA. In contrast, the patients with Roux-en-Y gastrectomy and the Billroth II patients with persistent HP infection had no change in anti-HP IgA after surgery. Anti-HP IgG showed variable results in the four patients without gastric HP infection and was not affected by gastrectomy in the patients with persistent HP infection. We concluded that serum anti-HP IgA, but not anti-HP IgG, is helpful in identifying those patients in whom HP is no longer demonstrable after Billroth II gastrectomy. Gastrectomy with Roux-en-Y anastomosis had no effect on gastric HP infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1748037     DOI: 10.1007/bf01296612

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  14 in total

1.  Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.

Authors:  B J Marshall; C S Goodwin; J R Warren; R Murray; E D Blincow; S J Blackbourn; M Phillips; T E Waters; C R Sanderson
Journal:  Lancet       Date:  1988 Dec 24-31       Impact factor: 79.321

Review 2.  Duodenal ulcer, Campylobacter pylori, and the "leaking roof" concept.

Authors:  C S Goodwin
Journal:  Lancet       Date:  1988 Dec 24-31       Impact factor: 79.321

Review 3.  Evaluation of surgical treatment of duodenal ulcer: short- and long-term effects.

Authors:  J C Thompson; I Wiener
Journal:  Clin Gastroenterol       Date:  1984-05

4.  Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels.

Authors:  G Oderda; D Vaira; J Holton; C Ainley; F Altare; N Ansaldi
Journal:  Lancet       Date:  1989-04-01       Impact factor: 79.321

5.  Enzyme-linked immunosorbent assay for Campylobacter pyloridis: correlation with presence of C. pyloridis in the gastric mucosa.

Authors:  C S Goodwin; E Blincow; G Peterson; C Sanderson; W Cheng; B Marshall; J R Warren; R McCulloch
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

6.  The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens.

Authors:  R Whitehead; S C Truelove; M W Gear
Journal:  J Clin Pathol       Date:  1972-01       Impact factor: 3.411

7.  Campylobacter pylori antibodies in humans.

Authors:  G I Perez-Perez; B M Dworkin; J E Chodos; M J Blaser
Journal:  Ann Intern Med       Date:  1988-07-01       Impact factor: 25.391

8.  Value of serology (ELISA and immunoblotting) for the diagnosis of Campylobacter pylori infection.

Authors:  A S Peña; H P Endtz; G J Offerhaus; A Hoogenboom-Verdegaal; W van Duijn; N de Vargas; G den Hartog; J Kreuning; J van der Reyden; R P Mouton
Journal:  Digestion       Date:  1989       Impact factor: 3.216

Review 9.  Campylobacter pylori and peptic ulcer disease.

Authors:  D Y Graham
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

10.  Effect of duodenal ulcer surgery and enterogastric reflux on Campylobacter pyloridis.

Authors:  H J O'Connor; M F Dixon; J I Wyatt; A T Axon; D C Ward; E P Dewar; D Johnston
Journal:  Lancet       Date:  1986-11-22       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.